Get the Stockscreener App
11.01
0.36%
-0.04
After Hours:
11.01
Research Alliance Corp Iii stock is traded at $11.01, with a volume of 1,657.
It is down -0.36% in the last 24 hours and up +5.97% over the past month.
Research Alliance Corporation III is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.
See More
Previous Close:
$11.05
Open:
$10.97
24h Volume:
1,657
Relative Volume:
0.32
Market Cap:
$100.17M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-1.70%
1M Performance:
+5.97%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$10.97
$11.36
1-Week Range:
$10.50
$12.86
52-Week Range:
$10.24
$12.86
Research Alliance Corp Iii Stock (RACC) Company Profile
Name
Research Alliance Corp Iii
Sector
Industry
Phone
(617) 778-2500
Address
600 FIFTH AVENUE, 23RD FLOOR, NEW YORK
Compare RACC vs LION, XXI, UMAC, CCXI, DMII
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RACC
Research Alliance Corp Iii
|
11.01 | 100.54M | 0 | 0 | 0 | 0.00 |
LION
Lionsgate Studios Corp
|
13.85 | 3.93B | 2.63B | -175.60M | 11.40M | -0.7173 |
XXI
Twenty One Capital Inc
|
5.02 | 1.71B | 0 | 4.35M | 456.40K | 0.3397 |
UMAC
Unusual Machines Inc
|
19.67 | 933.42M | 17.25M | -5.64M | -40.16M | -0.3337 |
CCXI
Churchill Capital Corp Xi
|
14.65 | 826.03M | 0 | 0 | 0 | 0.0647 |
DMII
Drugs Made In America Acquisition Ii Corp
|
10.09 | 642.10M | 0 | 8.58M | -1.11M | 0.134 |
Research Alliance Corp Iii Stock (RACC) Latest News
Henry William Stusnick Net Worth (2026) - GuruFocus
Research Alliance Holdings Iii Llc /cayman Net Worth (2026) - GuruFocus
Francis Sherman Adams Net Worth (2026) - GuruFocus
Research Alliance Corporation III (RACC) Stock Price, News & Analysis - MarketBeat
Research Alliance Holdings IV LLC Discloses Investment in Research Alliance Corporation IV with 17% Stake - TradingView
Research Alliance Corporation IV (RACD) sponsor reports 17% ownership - Stock Titan
Research Alliance Corp IV (RACD) investor group reports 5.5% ownership of Class A shares - Stock Titan
Biotechnology Value Fund (RACD) group reveals 6.4% Research Alliance stake - Stock Titan
Research Alliance Corporation IV Completes Initial Public Offering - TipRanks
Research Alliance IV prices IPO for $75M, deposits $75M trust; sponsor buys $2.75M private placement - TradingView
Commodore Capital takes 5.5% position in Research Alliance Corp IV (RACD) - Stock Titan
RACD Stock Latest News - TipRanks
Perceptive Advisors reports 7.7% RACD stake in Research Alliance Corporation IV (RACD) - Stock Titan
RACD SEC FilingsResearch Alliance Corp IV 10-K, 10-Q, 8-K Forms - Stock Titan
Research Alliance Corporation IV (RACD) Stock Price, News & Analysis - MarketBeat
Research Alliance Corporation IV (RACD) Stock Chart and Price History 2026 - MarketBeat
Research Alliance Corp IV (RACD) grants 275,000 shares to director entity - Stock Titan
Research Alliance Corp IV (RACD) sponsor gets 275K share grant - Stock Titan
Research Alliance Corporation IV (RACD) seeks $75M SPAC IPO - Stock Titan
Frontier tech research, news & data - MLQ.ai
RACD Price Today: Research Alliance Corporation IV Stock Price, Quote & Chart - MEXC
Research Alliance Corporation IV (RACD) 10K Form and Latest SEC Filings 2026 - MarketBeat
Research Alliance Corporation IV Prices $75 Million IPO, Targets Healthcare Sector on Nasdaq - Minichart
Research Alliance IV Completes $75 Million SPAC IPO, Inks Trust, Underwriting and $2.75 Million Private Deal - TradingView
Research Alliance Corporation IV (RACD) completes $75M IPO and trust funding - Stock Titan
Research Alliance Corp IV SEC Filing (Jul 13, 2026) - Stock Titan
Research Alliance Corp IV (NASDAQ: RACD) files exhibits-only registration update - Stock Titan
Research Alliance Corp IV (RACD) director reports 30K Class B convertible shares - Stock Titan
Research Alliance Corp IV (RACD) CFO files initial ownership statement - Stock Titan
Research Alliance Corp IV (RACD) holder discloses 1.26M Class B shares - Stock Titan
Research Alliance IV prices $75M SPAC IPO - MSN
Chutes & Ladders—SSM Health CEO elected chair of AHA; Northwell Health names first chief biotechnology officer - Fierce Healthcare
Research Alliance Corporation IV(NasdaqCM: RACD) added to NASDAQ Composite Index - marketscreener.com
Research Alliance Corporation IV prices $75 million IPO at $10.00 per share - scanx.trade
Research Alliance Corporation IV prices $75M IPO on Nasdaq By Investing.com - Investing.com South Africa
Research Alliance Corporation IV prices $75M IPO on Nasdaq - Investing.com
Research Alliance Corporation IV (RACD) Prices $75M IPO - SPACInsider
Research Alliance Corp IV (RACD) Stock News - Stock Titan
RACD|Research Alliance IV Ord Shs Class A|Price:10.235|Chg%:-0.405 - TradingKey
Research Alliance Corp IV (RACD) launches $75M healthcare SPAC IPO - Stock Titan
Price to earnings forward of Research Alliance Corporation III – BOATS:RACC - TradingView
CEO Matthew Hammond reports 1.26M Class B shares in Research Alliance (RACD) - Stock Titan
Governor reappoints 3 trustees to Purdue board - Purdue University
Form S-1/A Research Alliance Corporation IV For: 8 July By Investing.com - Investing.com Nigeria
The SBB Research Group Foundation Sponsors Boston Dance Alliance - Yahoo Finance
Research Alliance Corp Iii Stock (RACC) Financials Data
There is no financial data for Research Alliance Corp Iii (RACC). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
0.96%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):